Opioid-Induced Constipation (OIC) Treatment Market Report

Global Opioid-Induced Constipation (OIC) Treatment Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 08, 2022
  • PAGES：216
  • REPORT CODE：GMM851351
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Opioid-Induced Constipation (OIC) Treatment market report explains the definition, types, applications, major countries, and major players of the Opioid-Induced Constipation (OIC) Treatment market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Pfizer

    • GlaxoSmithKline

    • AstraZeneca

    • SLA Pharma

    • Cubist Pharmaceuticals

    • AIKO Biotechnology

    • Salix Pharmaceuticals

    • Takeda Pharmaceutical

    By Type:

    • Oral

    • Parenteral (Subcutaneous Injection)

    By End-User:

    • Drug Store

    • Independent Pharmacies

    • Hospital Pharmacies

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Opioid-Induced Constipation (OIC) Treatment Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Opioid-Induced Constipation (OIC) Treatment Outlook to 2028- Original Forecasts

    • 2.2 Opioid-Induced Constipation (OIC) Treatment Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Opioid-Induced Constipation (OIC) Treatment Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Opioid-Induced Constipation (OIC) Treatment Market- Recent Developments

    • 6.1 Opioid-Induced Constipation (OIC) Treatment Market News and Developments

    • 6.2 Opioid-Induced Constipation (OIC) Treatment Market Deals Landscape

    7 Opioid-Induced Constipation (OIC) Treatment Raw Materials and Cost Structure Analysis

    • 7.1 Opioid-Induced Constipation (OIC) Treatment Key Raw Materials

    • 7.2 Opioid-Induced Constipation (OIC) Treatment Price Trend of Key Raw Materials

    • 7.3 Opioid-Induced Constipation (OIC) Treatment Key Suppliers of Raw Materials

    • 7.4 Opioid-Induced Constipation (OIC) Treatment Market Concentration Rate of Raw Materials

    • 7.5 Opioid-Induced Constipation (OIC) Treatment Cost Structure Analysis

      • 7.5.1 Opioid-Induced Constipation (OIC) Treatment Raw Materials Analysis

      • 7.5.2 Opioid-Induced Constipation (OIC) Treatment Labor Cost Analysis

      • 7.5.3 Opioid-Induced Constipation (OIC) Treatment Manufacturing Expenses Analysis

    8 Global Opioid-Induced Constipation (OIC) Treatment Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Opioid-Induced Constipation (OIC) Treatment Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Opioid-Induced Constipation (OIC) Treatment Export by Region (Top 10 Countries) (2017-2028)

    9 Global Opioid-Induced Constipation (OIC) Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Oral Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Parenteral (Subcutaneous Injection) Consumption and Growth Rate (2017-2022)

    • 9.2 Global Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Drug Store Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Independent Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Opioid-Induced Constipation (OIC) Treatment Market Analysis and Outlook till 2022

    • 10.1 Global Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

      • 10.2.2 Canada Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

      • 10.2.3 Mexico Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

      • 10.3.2 UK Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

      • 10.3.3 Spain Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

      • 10.3.4 Belgium Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

      • 10.3.5 France Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

      • 10.3.6 Italy Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

      • 10.3.7 Denmark Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

      • 10.3.8 Finland Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

      • 10.3.9 Norway Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

      • 10.3.10 Sweden Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

      • 10.3.11 Poland Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

      • 10.3.12 Russia Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

      • 10.3.13 Turkey Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

      • 10.4.2 Japan Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

      • 10.4.3 India Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

      • 10.4.4 South Korea Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

      • 10.4.5 Pakistan Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

      • 10.4.6 Bangladesh Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

      • 10.4.7 Indonesia Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

      • 10.4.8 Thailand Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

      • 10.4.9 Singapore Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

      • 10.4.10 Malaysia Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

      • 10.4.11 Philippines Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

      • 10.4.12 Vietnam Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

      • 10.5.2 Colombia Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

      • 10.5.3 Chile Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

      • 10.5.4 Argentina Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

      • 10.5.5 Venezuela Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

      • 10.5.6 Peru Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

      • 10.5.7 Puerto Rico Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

      • 10.5.8 Ecuador Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

      • 10.6.2 Kuwait Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

      • 10.6.3 Oman Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

      • 10.6.4 Qatar Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

      • 10.7.2 South Africa Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

      • 10.7.3 Egypt Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

      • 10.7.4 Algeria Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

      • 10.8.2 New Zealand Opioid-Induced Constipation (OIC) Treatment Consumption (2017-2022)

    11 Global Opioid-Induced Constipation (OIC) Treatment Competitive Analysis

    • 11.1 Pfizer

      • 11.1.1 Pfizer Company Details

      • 11.1.2 Pfizer Opioid-Induced Constipation (OIC) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Pfizer Opioid-Induced Constipation (OIC) Treatment Main Business and Markets Served

      • 11.1.4 Pfizer Opioid-Induced Constipation (OIC) Treatment Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 GlaxoSmithKline

      • 11.2.1 GlaxoSmithKline Company Details

      • 11.2.2 GlaxoSmithKline Opioid-Induced Constipation (OIC) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 GlaxoSmithKline Opioid-Induced Constipation (OIC) Treatment Main Business and Markets Served

      • 11.2.4 GlaxoSmithKline Opioid-Induced Constipation (OIC) Treatment Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 AstraZeneca

      • 11.3.1 AstraZeneca Company Details

      • 11.3.2 AstraZeneca Opioid-Induced Constipation (OIC) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 AstraZeneca Opioid-Induced Constipation (OIC) Treatment Main Business and Markets Served

      • 11.3.4 AstraZeneca Opioid-Induced Constipation (OIC) Treatment Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 SLA Pharma

      • 11.4.1 SLA Pharma Company Details

      • 11.4.2 SLA Pharma Opioid-Induced Constipation (OIC) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 SLA Pharma Opioid-Induced Constipation (OIC) Treatment Main Business and Markets Served

      • 11.4.4 SLA Pharma Opioid-Induced Constipation (OIC) Treatment Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Cubist Pharmaceuticals

      • 11.5.1 Cubist Pharmaceuticals Company Details

      • 11.5.2 Cubist Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Cubist Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Main Business and Markets Served

      • 11.5.4 Cubist Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 AIKO Biotechnology

      • 11.6.1 AIKO Biotechnology Company Details

      • 11.6.2 AIKO Biotechnology Opioid-Induced Constipation (OIC) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 AIKO Biotechnology Opioid-Induced Constipation (OIC) Treatment Main Business and Markets Served

      • 11.6.4 AIKO Biotechnology Opioid-Induced Constipation (OIC) Treatment Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Salix Pharmaceuticals

      • 11.7.1 Salix Pharmaceuticals Company Details

      • 11.7.2 Salix Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Salix Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Main Business and Markets Served

      • 11.7.4 Salix Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Takeda Pharmaceutical

      • 11.8.1 Takeda Pharmaceutical Company Details

      • 11.8.2 Takeda Pharmaceutical Opioid-Induced Constipation (OIC) Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Takeda Pharmaceutical Opioid-Induced Constipation (OIC) Treatment Main Business and Markets Served

      • 11.8.4 Takeda Pharmaceutical Opioid-Induced Constipation (OIC) Treatment Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    12 Global Opioid-Induced Constipation (OIC) Treatment Market Outlook by Types and Applications to 2028

    • 12.1 Global Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Oral Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Parenteral (Subcutaneous Injection) Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Drug Store Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Independent Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Opioid-Induced Constipation (OIC) Treatment Market Analysis and Outlook to 2028

    • 13.1 Global Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

      • 13.2.2 Canada Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

      • 13.3.2 UK Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

      • 13.3.3 Spain Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

      • 13.3.5 France Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

      • 13.3.6 Italy Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

      • 13.3.8 Finland Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

      • 13.3.9 Norway Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

      • 13.3.11 Poland Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

      • 13.3.12 Russia Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

      • 13.4.2 Japan Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

      • 13.4.3 India Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

      • 13.5.3 Chile Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

      • 13.5.6 Peru Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

      • 13.6.3 Oman Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Opioid-Induced Constipation (OIC) Treatment Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Opioid-Induced Constipation (OIC) Treatment

    • Figure of Opioid-Induced Constipation (OIC) Treatment Picture

    • Table Global Opioid-Induced Constipation (OIC) Treatment Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Opioid-Induced Constipation (OIC) Treatment Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Oral Consumption and Growth Rate (2017-2022)

    • Figure Global Parenteral (Subcutaneous Injection) Consumption and Growth Rate (2017-2022)

    • Figure Global Drug Store Consumption and Growth Rate (2017-2022)

    • Figure Global Independent Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Opioid-Induced Constipation (OIC) Treatment Consumption by Country (2017-2022)

    • Table North America Opioid-Induced Constipation (OIC) Treatment Consumption by Country (2017-2022)

    • Figure United States Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Canada Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Mexico Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Opioid-Induced Constipation (OIC) Treatment Consumption by Country (2017-2022)

    • Figure Germany Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure UK Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Spain Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Belgium Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure France Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Italy Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Denmark Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Finland Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Norway Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Sweden Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Poland Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Russia Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Turkey Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Table APAC Opioid-Induced Constipation (OIC) Treatment Consumption by Country (2017-2022)

    • Figure China Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Thailand Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Singapore Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Philippines Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Table South America Opioid-Induced Constipation (OIC) Treatment Consumption by Country (2017-2022)

    • Figure Brazil Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Colombia Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Chile Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Argentina Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Peru Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Table GCC Opioid-Induced Constipation (OIC) Treatment Consumption by Country (2017-2022)

    • Figure Bahrain Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Oman Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Qatar Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Table Africa Opioid-Induced Constipation (OIC) Treatment Consumption by Country (2017-2022)

    • Figure Nigeria Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Africa Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Egypt Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure Algeria Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Table Oceania Opioid-Induced Constipation (OIC) Treatment Consumption by Country (2017-2022)

    • Figure Australia Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Opioid-Induced Constipation (OIC) Treatment Consumption and Growth Rate (2017-2022)

    • Table Pfizer Company Details

    • Table Pfizer Opioid-Induced Constipation (OIC) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Opioid-Induced Constipation (OIC) Treatment Main Business and Markets Served

    • Table Pfizer Opioid-Induced Constipation (OIC) Treatment Product Portfolio

    • Table GlaxoSmithKline Company Details

    • Table GlaxoSmithKline Opioid-Induced Constipation (OIC) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline Opioid-Induced Constipation (OIC) Treatment Main Business and Markets Served

    • Table GlaxoSmithKline Opioid-Induced Constipation (OIC) Treatment Product Portfolio

    • Table AstraZeneca Company Details

    • Table AstraZeneca Opioid-Induced Constipation (OIC) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca Opioid-Induced Constipation (OIC) Treatment Main Business and Markets Served

    • Table AstraZeneca Opioid-Induced Constipation (OIC) Treatment Product Portfolio

    • Table SLA Pharma Company Details

    • Table SLA Pharma Opioid-Induced Constipation (OIC) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table SLA Pharma Opioid-Induced Constipation (OIC) Treatment Main Business and Markets Served

    • Table SLA Pharma Opioid-Induced Constipation (OIC) Treatment Product Portfolio

    • Table Cubist Pharmaceuticals Company Details

    • Table Cubist Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cubist Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Main Business and Markets Served

    • Table Cubist Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Product Portfolio

    • Table AIKO Biotechnology Company Details

    • Table AIKO Biotechnology Opioid-Induced Constipation (OIC) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table AIKO Biotechnology Opioid-Induced Constipation (OIC) Treatment Main Business and Markets Served

    • Table AIKO Biotechnology Opioid-Induced Constipation (OIC) Treatment Product Portfolio

    • Table Salix Pharmaceuticals Company Details

    • Table Salix Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Salix Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Main Business and Markets Served

    • Table Salix Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Product Portfolio

    • Table Takeda Pharmaceutical Company Details

    • Table Takeda Pharmaceutical Opioid-Induced Constipation (OIC) Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Takeda Pharmaceutical Opioid-Induced Constipation (OIC) Treatment Main Business and Markets Served

    • Table Takeda Pharmaceutical Opioid-Induced Constipation (OIC) Treatment Product Portfolio

    • Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Parenteral (Subcutaneous Injection) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Drug Store Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Independent Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Opioid-Induced Constipation (OIC) Treatment Consumption Forecast by Country (2022-2028)

    • Table North America Opioid-Induced Constipation (OIC) Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Opioid-Induced Constipation (OIC) Treatment Consumption Forecast by Country (2022-2028)

    • Figure Germany Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Opioid-Induced Constipation (OIC) Treatment Consumption Forecast by Country (2022-2028)

    • Figure China Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Opioid-Induced Constipation (OIC) Treatment Consumption Forecast by Country (2022-2028)

    • Figure Brazil Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Opioid-Induced Constipation (OIC) Treatment Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Opioid-Induced Constipation (OIC) Treatment Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Opioid-Induced Constipation (OIC) Treatment Consumption Forecast by Country (2022-2028)

    • Figure Australia Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Opioid-Induced Constipation (OIC) Treatment Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US